A critical breakthrough in cancer investigation is emerging with the use of mini-antibodies to re-engage damaged p53. This essential cancer suppressor protein is frequently disabled in many forms of malignancies, https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research